Literature DB >> 7308847

Nocturnal growth hormone and gonadotrophin secretion in growth retarded children with Crohn's disease.

M J Farthing, C A Campbell, J Walker-Smith, C R Edwards, L H Rees, A M Dawson.   

Abstract

Although impaired growth hormone secretion in response to pharmacological stimuli occurs in some growth retarded children with Crohn's disease, its relationship to past and future th is uncertain. We have therefore determined the growth hormone and gonadotrophin response to the physiological stimulus of sleep by continuous venous sampling in five severely gonadotrophin profiles, the mean plasma hormone concentrations during the first five hours of sleep were determined. In three of the five patients, five hour mean growth hormone levels were reduced (3.8, 5.0, and 8.5 mU/l) compared with levels reported previously in normal short children (10-43 mU/l), although the pulsatile pattern of growth hormone secretion was preserved in all. Nocturnal growth hormone secretion was unrelated to the growth velocities of these children during both pre- and post-treatment assessment periods but a significant correlation was found between growth hormone concentration and a disease activity score (r = 0.79, P less than 0.05), suggesting that growth hormone release by the pituitary was influenced by the severity of the disease. Nocturnal growth hormone secretion was also correlated with gonadotrophin secretion (luteinising hormones, r = 0.99, and follicle stimulating hormone, r = 0.96; p less than 0.01) indicating more extensive hypothalamic-pituitary disturbance. These findings suggest that hypothalamic-pituitary function is depressed in growth retarded children with Crohn's disease, but that abnormalities of growth hormone secretion are unlikely to be directly involved in the growth retardation seen in this condition.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7308847      PMCID: PMC1419477          DOI: 10.1136/gut.22.11.933

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  33 in total

1.  Definitions of inflammatory bowel disease of unknown etiology.

Authors:  H Schachter; J B Kirsner
Journal:  Gastroenterology       Date:  1975-03       Impact factor: 22.682

2.  A case of apparent hypopituitarism complicating chronic inflammatory bowel disease in childhood and adolescence.

Authors:  J R Green; D P O'Donoghue; C R Edwards; A M Dawson
Journal:  Acta Paediatr Scand       Date:  1977-09

3.  Effect of diet and cold exposure on norepinephrine turnover in pancreas and liver.

Authors:  J B Young; L Landsberg
Journal:  Am J Physiol       Date:  1979-05

4.  Usefulness of post-sleep human growth hormone release as a test of physiologic growth hormone secretion.

Authors:  J W Mace; R W Gotlin; J F Sassin; D C Parker; L G Rossman
Journal:  J Clin Endocrinol Metab       Date:  1970-08       Impact factor: 5.958

5.  Effect of starvation on hypothalamic content of "somatotropin releasing factor" and pituitary growth hormone content.

Authors:  J Meites; N J Fiel
Journal:  Endocrinology       Date:  1965-09       Impact factor: 4.736

6.  New cannula for intermittent and continuous venous sampling without heparinisation.

Authors:  M J Farthing; A M Mattei
Journal:  Br Med J       Date:  1979-11-03

7.  Basal and stimulated serum growth hormone concentrations in inflammatory bowel disease.

Authors:  A Tenore; W F Berman; J S Parks; A M Bongiovanni
Journal:  J Clin Endocrinol Metab       Date:  1977-04       Impact factor: 5.958

8.  Sleep related human growth hormone (GH) release: a test of physiologic growth hormone secretion in children.

Authors:  J W Mace; R W Gotlin; P Beck
Journal:  J Clin Endocrinol Metab       Date:  1972-02       Impact factor: 5.958

9.  Nyctohemeral growth hormone levels in children with growth retardation and inflammatory bowel disease.

Authors:  R W Gotlin; R S Dubois
Journal:  Gut       Date:  1973-03       Impact factor: 23.059

10.  Growth, course, and prognosis after surgery for Crohn's disease in children and adolescents.

Authors:  D R Homer; R J Grand; A H Colodny
Journal:  Pediatrics       Date:  1977-05       Impact factor: 7.124

View more
  9 in total

Review 1.  Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?

Authors:  Laurent Peyrin-Biroulet; Mathias Chamaillard; Florent Gonzalez; Elodie Beclin; Cecilia Decourcelle; Laurent Antunes; Jérôme Gay; Christel Neut; Jean-Frédéric Colombel; Pierre Desreumaux
Journal:  Gut       Date:  2006-09-06       Impact factor: 23.059

Review 2.  Role of nutrition in inflammatory bowel disease: an overview.

Authors:  M L Clark
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

3.  Sellar inflammatory mass with inflammatory bowel disease.

Authors:  Hugh J Freeman; John Maguire
Journal:  Can J Gastroenterol       Date:  2010-01       Impact factor: 3.522

Review 4.  Inflammatory bowel disease in childhood.

Authors:  I W Booth; J T Harries
Journal:  Gut       Date:  1984-02       Impact factor: 23.059

5.  Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis.

Authors:  A B Ballinger; O Azooz; T El-Haj; S Poole; M J Farthing
Journal:  Gut       Date:  2000-05       Impact factor: 23.059

6.  Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease.

Authors:  A G Thomas; J M Holly; F Taylor; V Miller
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

7.  Juvenile onset inflammatory bowel disease: height and body mass index in adult life.

Authors:  A Ferguson; D M Sedgwick
Journal:  BMJ       Date:  1994-05-14

8.  Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease.

Authors:  S H Murch; V A Lamkin; M O Savage; J A Walker-Smith; T T MacDonald
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

9.  Increased energy expenditure in growing adolescents with Crohn's disease.

Authors:  G Zoli; P H Katelaris; J Garrow; G Gasbarrini; M J Farthing
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.